Reliable Medical Grade Home-Based Test for Self-Use for people with Sleep DIsord...
Reliable Medical Grade Home-Based Test for Self-Use for people with Sleep DIsorders
Sleep disorders are prevalent in 1/3 of the global population, across various age groups, and considered a public health epidemic. Nevertheless, sleep disorders are often unrecognized and under-reported. These disorders can contri...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
RTC-2015-3446-1
Nuevos paradigmas no hospitalarios para la simplificación de...
50K€
Cerrado
DPI2017-84280-R
SIMPLIFICACION DEL DIAGNOSTICO DE LA APNEA DEL SUEÑO INFANTI...
188K€
Cerrado
TIN2013-40686-P
ANALISIS INTELIGENTE DE SEÑALES NEUROLOGICAS Y CONSTRUCCION...
21K€
Cerrado
RTC-2017-6516-1
Estimación automática de la capacidad cognitiva en niños con...
62K€
Cerrado
INSOMNIA AID
Inventive Neurophysiology Software Outputting Measures of N...
150K€
Cerrado
PTQ-17-09344
Detección de alteraciones de sueño mediante el análisis del...
47K€
Cerrado
Información proyecto S-trodes
Duración del proyecto: 23 meses
Fecha Inicio: 2023-11-20
Fecha Fin: 2025-10-31
Líder del proyecto
XTRODES LTD
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
4M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Sleep disorders are prevalent in 1/3 of the global population, across various age groups, and considered a public health epidemic. Nevertheless, sleep disorders are often unrecognized and under-reported. These disorders can contribute to other medical problems, and some may also be symptoms for underlying mental health issues. Sleep monitoring is essential for reliable diagnosis and improved management of sleep disorders. Currently, sleep disorders are only measured during an overnight Polysomnography (PSG); however, this method is limited in clinical implication due its unavailability, high cost, unnatural sleep environment and episodic brain patterns. Smart Skin technology enables monitoring treatment efficacy: the platform is designed to replace PSG with home-based accessible technology. The EIC funding will enable X-trodes to optimize its platform and to perform the clinical validation activities necessary to obtain CE Mark and start commercialization in Europe.